InMode to Present at the Canaccord 42nd Annual Growth Conference

InMode Ltd. (NASDAQ: INMD) announced that CFO Yair Malca will present at the Canaccord 42nd Annual Growth Conference on August 11, 2022, at 3:30 PM ET, in Boston.

Rhea-AI Summary

InMode Ltd. (NASDAQ: INMD) announced that CFO Yair Malca will present at the Canaccord 42nd Annual Growth Conference on August 11, 2022, at 3:30 PM ET, in Boston. The presentation will be available via webcast on the company's Investor Relations website. Malca is also scheduled for one-on-one meetings with investors on August 10 and August 11. InMode specializes in innovative medical technologies, focusing on minimally invasive RF procedures in various medical fields.

Argus Session date unavailable

+4.94% session move Open Argus

Details

News Market Reaction – INMD

The recorded move for INMD in the trading session of this news was +4.94%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

YOKNEAM, Israel, July 20, 2022 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer, will present at the Canaccord 42^nd Annual Growth Conference on Aug. 11, 2022, at the InterContinental Boston hotel.

The presentation is scheduled for 3:30 pm Eastern Time on Thursday, Aug. 11 and will be webcast from InMode's Investor Relations website at https://inmodemd.com/investors/. Yair Malca will also hold one-on-one investor meetings on Wednesday, Aug. 10 and Thursday, Aug. 11. To schedule a meeting, please contact your Canaccord representative.

For more information about the event, visit InMode's investor relations site here.

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com   
917-607-8654 

Logo: https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-the-canaccord-42nd-annual-growth-conference-301589932.html

SOURCE InMode Ltd.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will InMode present at the Canaccord 42nd Annual Growth Conference?

InMode will present at the Canaccord 42nd Annual Growth Conference on August 11, 2022, at 3:30 PM ET.

Who is presenting for InMode at the conference?

Yair Malca, the Chief Financial Officer, will present for InMode at the conference.

How can I watch InMode's presentation at the conference?

InMode's presentation will be webcast on their Investor Relations website at https://inmodemd.com/investors/.

Are there one-on-one meetings available with InMode executives?

Yes, Yair Malca will hold one-on-one investor meetings on August 10 and August 11, 2022.

What are InMode's areas of focus?

InMode focuses on innovative medical technologies, particularly minimally invasive RF procedures across plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.